InsiderTrades.com logo
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
From Banyan Hill Publishing   |   Ad
If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)
Watch my video for all of the details

GCTK Insider Trading

Insider Ownership Percentage: 17.70%
Insider Buying (Last 12 Months): $230,000.40
Insider Selling (Last 12 Months): $0.00

GlucoTrack Insider Trading History Chart

This chart shows the insider buying and selling history at GlucoTrack by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GlucoTrack Share Price & Price History

Current Price: $0.61
Price Change: ▲ Price Increase of +0.06 (10.91%)
As of 05/3/2024 01:00 AM ET

This chart shows the closing price history over time for GCTK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
From Banyan Hill Publishing   |   Ad
If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)
Watch my video for all of the details

GlucoTrack Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/22/2024Drew SycoffDirectorBuy182,540$1.26$230,000.402,951,258View SEC Filing Icon  
See Full Table
Urgent Nvidia Warning
From Altimetry   |   Ad
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Click here to access…

SEC Filings (Institutional Ownership Changes) for GlucoTrack (NASDAQ:GCTK)

10.92% of GlucoTrack stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

GlucoTrack Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/10/2022Boston Financial Mangement LLC26,372$51K0.0%N/A0.170%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
GlucoTrack logo
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Read More on GlucoTrack

Today's Range

Now: $0.61
Low: $0.53
High: $0.61

50 Day Range

MA: $0.41
Low: $0.23
High: $0.90

52 Week Range

Now: $0.61
Low: $0.13
High: $0.99

Volume

114,938 shs

Average Volume

355,946 shs

Market Capitalization

$16.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.1

Who are the company insiders with the largest holdings of GlucoTrack?

GlucoTrack's top insider shareholders include:
  1. Drew Sycoff (Director)
Learn More about top insider investors at GlucoTrack.
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
From Banyan Hill Publishing   |   Ad
If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)
Watch my video for all of the details